SGSherif Armia Gaballa

Sherif Armia Gaballa

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Sherif Armia Gaballa has a total of 5 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Polyethylene glycol: Properties, applications, and challenges

    by Sherif Armia Gaballa, Youssef Naguib, Fatma Mohamed Mady, Khaled Ali Khaled

    Polyethylene glycol (PEG) is a versatile polymer with overwhelming properties that enhance its abundant use in different applications. It is widely used in the food industry, various biomedical and pharmaceutical applications, and many daily used products such as cosmetics. In addition, PEGylation, the covalent binding of PEG molecules to nanocarriers, proteins, peptides, or drug molecules, has been designed as a brilliant approach to improve the pharmacokinetics and therapeutic efficacy of PEGylated therapeutics. The extensive application of PEGylation in the drug delivery field is reflected by the increasing number of commercially available PEGylated therapeutics approved through the last two decades and many others are under clinical trials for sooner approval. However, anti-PEG antibodies, both induced after the treatment with PEGylated therapeutics or naturally occurring in healthy individuals, were reported to negatively affect the pharmacokinetics and the therapeutic efficacy of the administered PEGylated therapeutics through the so-called accelerated blood clearance (ABC) phenomenon. Furthermore, hypersensitivity reactions (HSRs) have been reported in several cases following the administration of PEGylated therapeutics or other PEG-containing products. In addition, PEG nonbiodegradability, PEG degradation, and toxicity associated with polymerization reaction residues are remaining challenges. As a result, numerous polymers have been developed and investigated as potential alternatives for PEG in drug delivery and other medical and pharmaceutical applications.


  • Cubosomes: composition, preparation, and drug delivery applications.

    by Sherif A. Gaballa, Omar H. El Garhy, Hamdy Abdelkader

    Cubosomes can be considered as a novel lipid-based nanosystems similar to well-known vesicular systems such as liposomes and niosomes. Cubosomes have been widely formulated using certain amphiphilic lipids (e.g. glyceryl monooleate and phytantriol) in the presence of a suitable stabilizer. They can represent a novel drug delivery system which could be loaded with hydrophilic, lipophilic and amphiphilic drug molecules. They are widely used for various drug delivery applications such as oral, ocular, transdermal and chemotherapy drug delivery. In this review, the pertinent literature of cubosomes with emphasis on theories of self-assembling, the composition of cubosomes, methods of preparation and drug delivery applications will be critically reviewed.